Patents by Inventor Athanasios TSIATIS

Athanasios TSIATIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPIES FOR TREATING UROTHELIAL CARCINOMA
    Publication number: 20240010701
    Abstract: Provided are methods of treating cancer (e.g., a urothelial cancer) that comprise administering a polypeptide (e.g. a fusion polypeptide) that comprises a SIRP?-D1 domain variant and an Fc domain variant in combination with an antibody-drug conjugate (e.g., enfortumab vedotin). Also provided are related kits.
    Type: Application
    Filed: May 31, 2023
    Publication date: January 11, 2024
    Inventors: Jaume PONS, Sophia RANDOLPH, Marija VRLJIC, Athanasios TSIATIS, Haiying LIU, Min Li, Amy Shaw-Ru CHEN
  • DNA Methylation and Mutational Analysis Methods for Bladder Cancer Surveillance
    Publication number: 20230374604
    Abstract: The present disclosure relates to methods of monitoring bladder cancer patients and analyzing patient samples for presence of methylated DNA and optionally particular gene mutations. In some embodiments, analysis results are correlated with clinical outcome measures such as risk of bladder cancer recurrence.
    Type: Application
    Filed: April 4, 2023
    Publication date: November 23, 2023
    Applicant: Genomic Health, Inc.
    Inventors: Margarita LOPATIN, Athanasios TSIATIS, Christopher N. SILK, David P. MILLER, Michael R. CRAGER, Phillip FEBBO, Dejan KNEZEVIC
  • DNA methylation and mutational analysis methods for bladder cancer surveillance
    Patent number: 11649506
    Abstract: The present disclosure relates to methods of monitoring bladder cancer patients and analyzing patient samples for presence of methylated DNA and optionally particular gene mutations. In some embodiments, analysis results are correlated with clinical outcome measures such as risk of bladder cancer recurrence.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: May 16, 2023
    Assignee: Genomic Health, Inc.
    Inventors: Margarita Lopatin, Athanasios Tsiatis, Christopher N. Silk, David P. Miller, Michael Crager, Phillip Febbo, Dejan Knezevic
  • Combinational drug therapies
    Patent number: 11628176
    Abstract: Disclosed is a method of treating a subject suffering from a cancer, comprising administering to the subject a combination of agents comprising: (a) Compound I: or a pharmaceutically acceptable salt thereof; and (b) one or more inhibitors of the androgen receptor signaling pathway; or (c) one or more PARP inhibitors; wherein the amount of the combination of agents is therapeutically effective in the treatment.
    Type: Grant
    Filed: August 20, 2021
    Date of Patent: April 18, 2023
    Assignee: OPNA BIO SA
    Inventors: Ben Powell, Athanasios Tsiatis, Jackie Walling
  • COMBINATIONAL DRUG THERAPIES
    Publication number: 20220054507
    Abstract: Disclosed is a method of treating a subject suffering from a cancer, comprising administering to the subject a combination of agents comprising: (a) Compound I: or a pharmaceutically acceptable salt thereof; and (b) one or more inhibitors of the androgen receptor signaling pathway; or (c) one or more PARP inhibitors; wherein the amount of the combination of agents is therapeutically effective in the treatment.
    Type: Application
    Filed: August 20, 2021
    Publication date: February 24, 2022
    Inventors: Ben Powell, Athanasios Tsiatis, Jackie Walling
  • DNA Methylation and Mutational Analysis Methods for Bladder Cancer Surveillance
    Publication number: 20200165686
    Abstract: The present disclosure relates to methods of monitoring bladder cancer patients and analyzing patient samples for presence of methylated DNA and optionally particular gene mutations. In some embodiments, analysis results are correlated with clinical outcome measures such as risk of bladder cancer recurrence.
    Type: Application
    Filed: May 17, 2018
    Publication date: May 28, 2020
    Applicant: Genomic Health, Inc.
    Inventors: Margarita LOPATIN, Athanasios TSIATIS, Christopher N. SILK, David P. Miller, Michael CRAGER, Phillip FEBBO, Dejan KNEZEVIC